Exploring the Impact of Adjuvants on Vaccine Immunity Through Hematopoietic Cells

Yuhyun Ji(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nicole Lea Sullivan(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kunal Bakshi(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kavitha Bekkari(Merck & Co., Inc., Rahway, NJ, USA (United States)), SamMoon Kim(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kristina Tracy(Merck & Co., Inc., Rahway, NJ, USA (United States)), William J. Smith(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jennifer A. Kriss(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yaping Liu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Shailaa Kummar(Merck & Co., Inc., Rahway, NJ, USA (United States)), Celia LaPorta(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mohammed Shardar(Merck & Co., Inc., Rahway, NJ, USA (United States)), Geoffrey A. Walford(Merck & Co., Inc., Rahway, NJ, USA (United States)), Willis Read-Button(Merck & Co., Inc., Rahway, NJ, USA (United States)), Lorenzo Chen(Merck & Co., Inc., Rahway, NJ, USA (United States)), Rachel Graham(Merck & Co., Inc., Rahway, NJ, USA (United States)), Colleen Barr(Merck & Co., Inc., Rahway, NJ, USA (United States)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States))
Vaccines
February 5, 2026
Cited by 0


Related Papers